Orchestra BioMed Holdings, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/74e4236a-6d00-4d07-9d88-3c07d48cd4f1/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-52.7M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-026754 |
| FY 2024 | $-61.0M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-004161 |
| FY 2023 | $-49.1M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-004083 |
| FY 2022 | $-33.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-24-004083 |
| FY 2021 | $-378.8k | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-016849 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Orchestra BioMed Holdings, Inc. — all facts · Revenue · Operating Income